Company ProfilePremium

Aekyung Chemical Co., Ltd.

Company Profile Analysis

Ticker: 161000.KS애경케미칼 주식회사

ESOMAR 23 Corporate BadgeISO Certifications Badge
Aekyung Chemical Co., Ltd. - Company showcase

Year Founded & Workforce

2012

700 Employees

Aekyung Chemical Co., Ltd. logo

Aekyung Chemical Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Aekyung Chemical Co., Ltd. Overview

Aekyung Chemical is the chemicals arm of Korea's Aekyung Group, formed in November 2021 by merging Aekyung Petrochemical, Aekyung Chemical and AK ChemTech. It is Korea's largest producer of phthalic anhydride and plasticizers, and also makes unsaturated polyester and coating resins, surfactants, refined glycerin, biodiesel and bio-heavy oil. Revenue peaked at KRW 2.18 trillion in FY2022 and fell to KRW 1.45 trillion in FY2025, when Chinese overcapacity in commodity plasticizers pushed the company into its first post-merger operating loss (KRW −10.2 bn). Management's answer is a shift toward higher-value materials: Korea's first terephthaloyl chloride (TPC) plant for aramid fibre (15,000 t/yr, completed March 2026), hard-carbon anode material for sodium-ion batteries, and a Southeast Asian surfactant network in Vietnam and Indonesia. First-half 2026 results recovered sharply. A Korea Fair Trade Commission cartel case over biofuel tenders, with a possible criminal referral, is the largest unquantified liability.


What the company does. Aekyung Chemical is a mid-sized, diversified intermediate and specialty chemicals producer. Its filings define four strategic operating divisions: Plasticizers, Synthetic Resins, Household (Life) Chemicals, and Bio & Energy. A small "Other" line covers steam sales and an arts, sports and leisure service activity (FY2024 Business Report). FnGuide's company profile (2 Sept 2026) describes a mid-tier company with 11 consolidated subsidiaries producing phthalic anhydride, plasticizers, unsaturated polyester resin and surfactants. It credits the company with the leading domestic share in phthalic anhydride and sole domestic supply of isocyanate hardeners.

The company's own description (paraphrased). Recruitment and corporate materials present Aekyung Chemical as a comprehensive chemical company. It supplies raw materials and materials that are embedded in daily life: plasticizers, biodiesel, composite-material resins, surfactants and battery anode materials. It runs global operations in Korea, China and Vietnam (Saramin company profile, 2026). The post-merger business description in DART filings stresses expansion into four divisions and a focus on environmentally friendly products.

Independent characterization. In economic terms this is a spread business. The largest division (47.6% of FY2024 revenue) converts ortho-xylene into phthalic anhydride and then, with oxo-alcohols, into PVC plasticizers. Margins depend on the gap between product prices and feedstock costs, and on regional supply and demand. Chinese capacity additions have compressed that gap since 2022. The resin and surfactant divisions are closer to formulated products, with stickier customers and steadier margins, but they are sub-scale by global standards. The Bio & Energy division sells into tender markets created by regulation: the Renewable Fuel Standard (RFS) for diesel blending and the Renewable Portfolio Standard (RPS) for power generation. Demand there is set by policy, and pricing is set by competitive bidding. That bidding process is now the subject of an antitrust case.

Revenue model. Almost all revenue is product sales (manufactured goods plus some traded merchandise). There are no subscription or licensing revenues of note. Services are immaterial and sit within "Other" at 2.6% of FY2024 revenue.

Value chain position. The company is midstream. It buys petrochemical feedstocks (ortho-xylene, alcohols, styrene, glycols), oleochemical feedstocks (palm-derived fatty alcohols and oils, used cooking oil) and sells to converters and formulators.

Customer types and end-markets.

Strategy

Stated themes (paraphrased from company statements). Management has said it will build a global production system and improve cost competitiveness in existing businesses. It will also keep developing high-value products, and move quickly on TPC and hard carbon (company comment in DealSite, Sept 2025). A group spokesperson described the company as laying a technology base for future growth (Lead Economy, Apr 2026).

Initiatives in the last 24 months.

FY2025 revenue was about 36% of that figure. No current-year guidance was found. Korean mid-caps rarely give one.

Cost programmes. No quantified cost-reduction programme was found in the sources reviewed.

Products & Services

Pricing is negotiated or tender-based, and no list prices are disclosed. Launch years are given only where sourced. Product grades marked "recollection" are from general industry knowledge of the company's range and should be confirmed against the product pages.

Plasticizers division

ProductDescription and useTarget customerNotes
Phthalic anhydride (PA)Made from ortho-xylene; feedstock for plasticizers, UPR and alkyd resins, dyesPlasticizer and resin makers; captive useLeading domestic share (FnGuide)
General phthalate plasticizers (DOP/DEHP, DINP, DIDP)PVC softening agents for flooring, sheet, wire and cable, wall coveringPVC convertersGrades: recollection. Commodity products exposed to Chinese supply (DealSite)
Non-phthalate plasticizers (DOTP and related, NEO-T brand family)Terephthalate plasticizers for consumer-contact and regulated usesFlooring, medical and toy-grade PVC makersBrand: recollection
Recycled-PET-based eco plasticizerPlasticizer made using waste PET as raw material; in mass productionCustomers with recycled-content targetsFnGuide (Sept 2026); company R&D release (Apr 2026); ISCC PLUS and GRS certifications obtained
Lubricant base oil (synthetic ester type)Ester base stocksLubricant formulatorsListed in segment definition (FY2024 Business Report)
TPC (terephthaloyl chloride)Key monomer for para-aramid fibre; 15,000 t/yr plant at Ulsan completed March 2026; uses a photo-chlorination ("light") process that suppresses SO2 and HCl by-product formationAramid fibre producersIlyo Weekly; Lead Economy. FnGuide refers to "chlorinated products" being commercialized

Synthetic Resins division

ProductDescription and useTarget customerNotes
Unsaturated polyester resin (UPR)Thermoset resin for composites (FRP), artificial marble, constructionComposite fabricatorsFY2024 Business Report
Coating resins (acrylic, alkyd, polyester)Binder resins for paintsPaint manufacturersFY2024 Business Report
Hardeners (isocyanate type)Curing agents for polyurethane coatingsPaint and coating makersSole domestic supplier per FnGuide
Recycled-MMA-based coating resinCoating resin from regenerated methyl methacrylateCoatings customers with sustainability targetsWater Journal (2024)
Biodegradable fertilizer coating resinCoating for controlled-release fertilizer; in mass productionFertilizer producersCompany R&D release (Apr 2026)
Fire-safe construction material resinBuilding material with improved fire safety; international certification obtainedConstruction materials makersWater Journal (2024)
Polyurethane (PU) resinsListed in the parent-company product mixIndustrial usersJobKorea

Household Chemicals division

ProductDescription and useTarget customerNotes
Anionic surfactants (ASCO series, e.g. ASCO1416)Cleaning actives for detergents and personal careDetergent and personal-care formulatorsProduct name appears in FY2024 Business Report
Other surfactants (nonionic, amphoteric, specialty)Formulation ingredientsHome and personal care, industrialGeneral range: recollection
Industrial emulsifiersFunctional raw materials; dedicated development team since the Jan 2026 R&D reorganizationIndustrial userseToday, 23 Jan 2026
Refined glycerinCo-product of oleochemical and biodiesel chains; humectant and chemical raw materialPersonal care, food, pharma, chemicalsFY2024 Business Report

Bio & Energy division

ProductDescription and useTarget customerNotes
BiodieselFatty acid methyl ester blended into automotive diesel under the RFS (4% blend in 2026)Korean refiners, by tenderMoney Today, 30 Jul 2026
Bio-heavy oilPower-generation fuel under the RPSPower generators, by tenderSame
Hard-carbon anode materialAnode material for sodium-ion and lithium-ion batteries; bio-mass-based feedstock; near-spherical particles give good coatability and electrode density; Jeonju plantBattery cell makers and EV makers (sample testing)Money Today, Seoul Economic Daily, 4 Dec 2025

Other

Steam sales and an arts, sports and leisure service activity (2.6% of FY2024 revenue).

Financial Narrative

All figures are consolidated K-IFRS. FY2021 includes the merged businesses only from 1 November 2021.

Income statement

Sources: Hankyung/NICE consolidated statements; company IR page for FY2023–FY2025 cross-check; FnGuide for FY2025 EBITDA (KRW 41.93 bn) and DPS. FY2024 EPS is shown as zero by the Hankyung feed; 82 is derived from controlling net income of KRW 3.98 bn over about 48.3 m shares.

Margins and growth

Revenue CAGR FY2021–FY2025: about −1.9% (derived). From the FY2022 peak to FY2025: about −12.6% a year (derived).

Balance sheet

FY2023–FY2025 are from the company IR page. FY2021–FY2022 are derived by back-solving from Hankyung/NICE growth rates and debt ratios.

Cash flow

Known investing commitments are the KRW 96.7 bn TPC plant (investment period September 2024 to end-2025), the Indonesian plant purchase (price not disclosed in sources reviewed) and the Jeonju hard-carbon line (amount not disclosed in sources reviewed). The dividend for FY2025 implies a payout of roughly KRW 6.8 bn (derived: KRW 140 on about 48.3 m shares net of treasury).

Ratios

Source: Hankyung/NICE. ROE and ROA here use total net income. The company's own IR page reports ROE of 4.52%, 0.54% and −0.41% for FY2023–FY2025, which is on a controlling-interest basis. Both are shown because they differ. ROIC and net debt/EBITDA: not calculable without the debt and cash figures. The cash conversion cycle is derived from the three turnover ratios, with payables turnover on a revenue basis as the vendor defines it.

Commentary

Revenue. FY2022 was the peak, lifted by high product prices and the first full year of the merged businesses. Revenue then fell for three straight years, by a cumulative KRW 724 bn. Management attributes this to Chinese capacity additions and weak global demand (Bizhankook; CEO Score Daily).

Gross profit. Gross margin slid only two points (10.2% to 8.2%), but on a shrinking revenue base that cut gross profit by KRW 103 bn from FY2022 to FY2025.

Operating income. SG&A stayed in a KRW 125–131 bn band while gross profit fell, so operating leverage worked in reverse. The FY2025 operating loss came from costs that did not flex, more than from a collapse in gross margin. Quarterly operating results in 2025 were about KRW +3.4 bn, −0.8 bn, −7.3 bn and, by derivation, roughly −5.5 bn.

Pre-tax and net income. FY2025 pre-tax income stayed positive at KRW 5.6 bn because non-operating income (KRW 60.6 bn) exceeded non-operating expense (KRW 44.8 bn). A tax charge of KRW 10.6 bn, larger than pre-tax income, then produced a net loss of KRW 4.9 bn. In FY2024 minority interests took KRW 4.5 bn of the KRW 8.5 bn net income, so controlling-shareholder profit was only KRW 4.0 bn.

Balance sheet. Assets grew every year from FY2022 while equity was flat and then fell, so liabilities funded the investment programme. The liabilities-to-equity ratio rose from 0.69x to 0.95x. The current ratio fell to 1.04x and net working capital to 1.3% of assets, which leaves little liquidity headroom.

Coverage and working capital. Interest coverage fell from 30.8x to 1.1x in FY2024 and turned negative in FY2025. Receivables turnover dropped from 9.3x to 6.0x in FY2025, which lengthened the derived cash conversion cycle by about 24 days. Possible explanations include longer export terms, the timing of year-end sales, or the consolidation of the Indonesian plant.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsMain entities

Plasticizers

Plasticizers, phthalic anhydride, lubricant base oil

Aekyung Chemical; Aekyung (Ningbo) Chemical (11.4% of sales)

Synthetic Resins

Unsaturated polyester resin (UPR), coating resins, hardeners

Aekyung Chemical

Household Chemicals

Surfactants, refined glycerin

Aekyung Chemical; AK VINA; Indonesian plant from Nov 2025. The filing also lists Aekyung Specialty Paint in this area of the subsidiary table

Bio & Energy

Biodiesel, bio-heavy oil, hard carbon

Aekyung Chemical

Other

Steam; arts, sports and leisure services

—

Revenue by Segment

MetricFY2022FY2023FY2024FY2025

Plasticizers revenue (KRW Bn)

1,014.7—781.3—

Synthetic Resins revenue (KRW Bn)

——209.6—

Household Chemicals revenue (KRW Bn)

——344.0—

Bio & Energy revenue (KRW Bn)

376.0—264.0—

Other revenue (KRW Bn, derived residual)

——43.4—

Total consolidated revenue (KRW Bn)

2,176.41,793.71,642.21,452.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment (%)

MetricFY2022FY2024

Plasticizers share (%)

46.647.6

Synthetic Resins share (%)

—12.8

Household Chemicals share (%)

—20.9

Bio & Energy share (%)

17.316.1

Other share (%)

—2.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (KRW Bn)

1,570.12,176.41,793.71,642.21,452.3

Cost of sales (KRW Bn)

1,412.21,954.31,617.71,501.41,333.3

Gross profit (KRW Bn)

157.9222.1176.1140.8119.0

SG&A (KRW Bn)

64.6127.1131.0125.4129.2

Operating income (KRW Bn)

93.395.145.115.5-10.2

EBITDA (KRW Bn, derived from margin)

109.9128.680.753.242.0

Pre-tax income (KRW Bn)

97.692.841.09.35.6

Income tax (KRW Bn)

20.333.48.00.810.6

Net income (KRW Bn)

77.359.433.08.5-4.9

Net income to controlling shareholders (KRW Bn)

77.460.133.14.0-2.9

EPS basic (KRW)

2,3021,24968682-61

Dividend per share (KRW)

————140

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

10.0610.219.828.588.19

Operating margin (%)

5.944.372.510.94-0.70

EBITDA margin (%)

7.005.914.503.242.89

Net margin (%)

4.922.731.840.52-0.34

Revenue growth (%)

72.7638.62-17.58-8.45-11.56

Operating income growth (%)

62.231.96-52.61-65.69—

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (KRW Bn)

1,244.91,234.11,308.41,356.41,394.3

Total liabilities (KRW Bn)

555.8505.9572.0615.5677.9

Total equity (KRW Bn)

689.1728.1736.3741.0716.4

Book value per share (KRW)

14,24314,96715,13715,14214,678

Margin Analysis (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE (%)

14.318.384.501.15-0.68

ROA (%)

8.704.792.590.64-0.36

Current ratio (x)

1.261.251.221.161.04

Quick ratio (x)

0.680.710.750.660.64

Total liabilities / equity (x)

0.810.690.780.830.95

Equity ratio (%)

55.3559.0056.2854.6351.38

Interest coverage (x)

30.7810.153.891.13-0.57

Asset turnover (x)

1.771.761.411.231.06

Inventory turnover (x)

8.888.147.437.367.09

Receivables turnover (x)

11.7611.059.469.275.97

Payables turnover (x)

15.1715.7214.7615.0415.36

Cash conversion cycle (days, derived)

4855636589

Net working capital / total assets (%)

9.879.558.215.101.27

Segment Overview — Plasticizers

SegmentExportDomesticTotal

Plasticizers

587.7193.5781.3

Synthetic Resins

80.9128.7209.6

Household Chemicals

172.5171.6344.0

Bio & Energy

——264.0

Three-segment subtotal (derived)

841.1493.81,334.9

Revenue by Region

MetricFY2022FY2023FY2024

Plasticizers domestic revenue (KRW Bn)

469.2237.9193.5

Plasticizers total revenue (KRW Bn)

1,014.7—781.3

Plasticizers export revenue (KRW Bn, derived)

545.5—587.7

Revenue by Region (Half-Yearly)

MetricH1 2024H1 2025

Bio & Energy revenue (KRW Bn)

131.584.2

Share Price & Returns

PeriodReturn (%)

1 month

5.83

3 months

12.38

6 months

-28.36

1 year

8.90

Valuation Snapshot

MultipleValue

P/E

Not meaningful (loss)

P/B

0.74

EV/EBITDA

22.54

Price/cash flow

19.01

Dividend yield (%)

1.29

Valuation Multiples (x)

MetricFY2021FY2022FY2023FY2024FY2025

P/B (x)

0.760.59—0.450.65

EV/EBITDA (x)

6.754.7214.0912.5621.12

P/E (x)

4.717.10———

Beta

0.851.22—1.321.12

Analyst Conclusions

Guidance and consensus. The company has issued no numerical guidance in the sources reviewed, and there is no broker consensus. The only hard forward indicator is the H1 2026 result.

H1 2026 arithmetic (derived, not reported figures). H1 2025 revenue was KRW 746.2 bn and operating profit KRW 2.7 bn. Applying the reported growth rates gives H1 2026 revenue of roughly KRW 874 bn and operating profit of roughly KRW 48–50 bn. Q1 2026 was KRW 370.6 bn and KRW 5.8 bn. That implies Q2 2026 revenue of about KRW 500 bn and operating profit above KRW 40 bn, which would be the strongest quarter since 2022. FnGuide attributes the improvement partly to RPS-driven Bio & Energy demand. These implied numbers should be checked against the half-year report before being used.

Bull case

  1. Earnings have turned. H1 2026 operating profit is many times FY2024's full-year KRW 15.5 bn, on a cost base that did not grow.

  2. TPC gives the company a domestic monopoly position in a specialty monomer that Korea used to import entirely, with logistics and lead-time advantages over Chinese supply.

  3. At 0.74x book, the market is pricing little value for the hard-carbon and Southeast Asian options.

Bear case

  1. The KFTC case could produce a fine that is large relative to a KRW 530 bn market capitalization and KRW 716 bn of equity, and criminal referrals. The amount is unknown and may not be provided for.

  2. The core plasticizer business has structural overcapacity. A single strong quarter may reflect temporary spreads or tender timing.

  3. The balance sheet has less room than before (liabilities/equity 0.95x, current ratio 1.04x), while three projects still need ramp-up funding and the parent group has reason to keep dividends flowing.

Catalysts and monitorables (next 12 months)

  • KFTC full-commission decision: fine amount, treatment of cover bidding, criminal referral.

  • Q3 2026 report (due by 16 November 2026): whether Q2 profitability held, and any provision.

  • TPC: named customers, qualification and utilization.

  • Hard carbon: first supply contract.

  • Vietnam Lotus Project start-up and Indonesian plant contribution.

  • New CEO's first strategy statement and any cost programme.

  • Receivables and working-capital trend.

  • Plasticizer utilization and domestic share.

Analyst verdict. Aekyung Chemical is a commodity-exposed chemical company trying to convert a decade of in-house research into specialty earnings. The evidence divides into three parts.

The first is the legacy business. From FY2022 to FY2025, revenue fell by a third and the operating margin went from 4.4% to below zero. The cause is well documented: Chinese plasticizer capacity displaced the company in its home market. Utilization near half of capacity shows the problem is structural.

The second is the response. Management built Korea's first TPC plant on schedule, bought a surfactant plant in Indonesia, and moved hard carbon to pilot scale. These are credible steps, and the R&D record behind them is real. None has yet produced disclosed revenue or a named customer.

The third is the 2026 rebound. The half-year numbers imply a very strong second quarter. Until the drivers are read from the filing, it is unsafe to treat this as a new run-rate.

Over all three sits the cartel case. The alleged conduct spans eleven years in a division that contributed about a sixth of revenue. The possible penalty is unquantified, and the outcome is binary in its effect on equity value and on the reputations of management and the board. The mid-year change of chief executive adds a further unknown.

On balance, the investment debate is no longer about whether the company can earn money in 2026. It is about how much of that is durable, and how much the regulator will take. This synthesis is analysis, not an investment recommendation.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Governance Overview

ItemDetailSource

Board size

8 directors

Digital Today via Nate

Outside directors

3 (37.5%)

Same

Audit committee

Composed entirely of outside directors

Same

New non-executive director

Jung Seok, head of strategic planning at AK Holdings; formerly A.T. Kearney principal, Aekyung Industrial growth strategy, AK Plaza strategy head

Business Post

Other holding-company director

Min Pung-gi, AK Holdings executive, joined the board at the 2025 AGM

The Bell via CB Insights

Re-elected outside director

Woo Yong-sang (audit committee member)

GoInsider

Major Shareholders

HolderSharesStake (%)

AK Holdings and 11 related parties

30,302,50962.29

Treasury shares

368,3360.76

Other reporting holders (6)

45,4940.09

Foreign ownership (aggregate)

—0.44

Free float

—36.87

Competitive Landscape

Competitors by Segment

SegmentCompetitorsBasis

Plasticizers and PA

LG Chem; Hanwha Solutions; OCI (PA); Chinese producers such as Bluesail; UPC Technology and Nan Ya Plastics (Taiwan); global majors BASF, Evonik, ExxonMobil Chemical, Eastman

Industry knowledge; press confirms Chinese producers as the main pressure

Synthetic resins

Sewon Chemical; other Korean UPR and coating-resin makers; Polynt-Reichhold, AOC (global)

Industry knowledge

Surfactants

Miwon Commercial; KCI; LG Household & Health Care's captive supply; BASF, Stepan, Kao, Wilmar-related oleochemical producers

Industry knowledge

Biodiesel and bio-heavy oil

DS Dansuk; SK Eco Prime; SK Chemicals (former business); Emac Solution; JC Chemical; KG Eco Solution

KFTC list of seven respondents

Hard carbon

Kuraray; Chinese producers (e.g. BTR, Shanshan)

Industry knowledge

TPC

Chinese merchant suppliers; captive production at global aramid majors

Industry knowledge; Korea previously imported all its TPC (Lead Economy)

Peer Comparison FY2025

DimensionAekyung Chemical (FY2025)LG Chem / Hanwha Solutions

Revenue scale

KRW 1.45 trillion

Many times larger; plasticizers are a small part of each

Operating margin

−0.70%—

R&D intensity

1.6% of revenue

—

Plasticizer feedstock integration

Integrated back to PA; buys ortho-xylene and alcohols

Stronger upstream integration (alcohols, PVC chain)

Recent Developments

--

Company Snapshot

$1,022M

Revenue

700

Employees

2012

Founded

SWOT Analysis

Strengths

  • Leading domestic share in phthalic anhydride and the number one position in Korean plasticizers (FnGuide; DealSite).
  • Sole domestic supplier of isocyanate hardeners (FnGuide) and, since March 2026, the only Korean TPC producer at 15,000 t/yr.
  • Diversified mix: no division above 48% of FY2024 revenue; Household Chemicals at 20.9% is split almost evenly between export and domestic.
  • Stayed profitable at the operating level in FY2022–FY2024 while many Korean chemical companies reported losses (CEO Score Daily).
  • R&D spending rose three years running to KRW 22.9 bn, 1.6% of revenue, during a downturn.
  • Stable control: AK Holdings group holds 62.29%; equity ratio still 51.4% at end-FY2025.
  • Proprietary technology developed over a decade (TPC since the mid-2010s, hard carbon since 2012).

Weaknesses

  • Revenue down 33% from FY2022 to FY2025 (KRW 2,176.4 bn to KRW 1,452.3 bn).
  • Operating margin fell every year from 5.94% (FY2021) to −0.70% (FY2025).
  • SG&A held at about KRW 125–131 bn while gross profit fell KRW 103 bn; the cost base did not adjust.
  • Utilization of 53.9% in plasticizers and 50.6% in resins in Q1 2025.
  • Liquidity thinning: current ratio 1.04x, net working capital 1.27% of assets, interest coverage negative in FY2025.
  • Receivables turnover fell from 9.27x to 5.97x in FY2025.
  • Negligible institutional following: foreign ownership 0.44%; no broker target price in the last three months (FnGuide).

Opportunities

  • Import substitution in TPC: Korea previously imported 100% of its needs.
  • Sodium-ion battery adoption, with hard-carbon demand forecast to grow above 30% a year.
  • Southeast Asian surfactant demand served from Vietnam and Indonesia.
  • Regulation-driven biofuel demand; RPS demand supported 2026 results.
  • Certified recycled and bio-based products (ISCC PLUS, GRS) toward the 50% eco-revenue goal for 2030.
  • Operating leverage in a recovery: H1 2026 operating profit rose 1,732.8% on a 17.1% revenue increase.

Threats

  • KFTC cartel case: affected tenders of KRW 9.71 trillion across seven companies; fines can reach 20% of relevant sales; criminal referral of the company and current and former staff recommended.
  • Parallel prosecution investigation (search in January 2026).
  • Continued Chinese plasticizer oversupply; domestic plasticizer sales already down 59% in two years.
  • Weak aramid demand at prospective TPC customers.
  • Execution risk from running three growth projects at once, with near-term cost burden (Lead Economy).
  • Group dependence: after the sale of Aekyung Industrial the holding company relies more on this business (DealSite), which may affect dividend and capital-allocation decisions.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
30 May 2025Q1 2025 results: revenue KRW 370.0 bn; operating profit about KRW 3.4 bnLast profitable quarter of 2025
Jul 2025EBN reports Q1 utilization: plasticizers 53.9%, resins 50.6%, Bio & Energy 51.7%Half-idle core plants
19 Aug 2025Q2 2025: revenue KRW 376.2 bn; operating loss about KRW 0.8 bnTurn to loss
Aug 2025H1 2025: revenue KRW 746.2 bn (−13% YoY), operating profit KRW 2.7 bn (−77%)DealSite
Sep 2025Press reports KFTC investigation of biodiesel pricing involving Aekyung Chemical and DS DansukFirst public sign of the cartel case
Sep 2025Group sale of Aekyung Industrial to Taekwang reportedRaises the company's weight within the group
31 Oct 2025Evonik Indonesian surfactant plant acquisition closesThird overseas manufacturing country
14 Nov 2025Q3 2025: revenue KRW 357.8 bn; operating loss KRW 7.3 bnLoss widens
4 Dec 2025Hard-carbon R&D complete; Jeonju expansion approvedBattery-materials option moves to pilot scale
Jan 2026Prosecutors search Aekyung Chemical, SK Eco Prime, DS Dansuk and related partiesCriminal track opens alongside the KFTC case
23 Jan 2026R&D reorganizationFocus on core areas
26 Jan 2026Cash dividend decision and record-date closure disclosedDPS KRW 140 for FY2025
27 Jan 2026Press confirms first post-merger annual lossCEO Score Daily
9 Feb 2026Disclosure of 15%+ change in profit structure; AGM convenedFY2025: revenue KRW 1,452.3 bn; operating loss KRW 10.2 bn
Feb–Mar 2026Q4 2025 corrected figures: revenue KRW 348.4 bn; net loss KRW 10.6 bnGoInsider disclosure summary
16 Mar 2026Board approves FY2025 financial statements (unqualified opinion)Reported to AGM in place of a vote
23 Mar 2026One outside director resignsBoard change
24 Mar 2026AGM: articles amended; Jung Seok elected; Woo Yong-sang re-elected; director pay cap approvedTighter holding-company link
26–27 Mar 2026TPC plant completedStrategic milestone; shares rise about 19% intraday on 27 March to KRW 11,090
30 Mar 2026Shares hit the daily limit, closing at KRW 14,820Re-rating on the TPC story
31 Mar 2026Shares trade at KRW 18,000 shortly after the open (+21%)Peak period; 52-week high KRW 19,960
7 Apr 2026Press reviews the three growth projects and the monetization riskLead Economy
20 Apr 2026Company publicizes three years of rising R&D spendKRW 22.9 bn in FY2025
15 May 2026Q1 2026: revenue KRW 370.6 bn (+0.2% YoY); operating profit KRW 5.8 bn; net loss KRW 1.4 bnReturn to operating profit
About 1 Jun 2026CEO change: Kim Sung-wan replaces Pyo Kyoung-wonLeadership transition
30 Jul 2026KFTC examiner's report served on seven biofuel producersFine, corrective order and criminal referral recommended
Mid-Aug 2026H1 2026: revenue +17.1% YoY; operating profit +1,732.8% YoY; net income positiveSharp recovery (FnGuide)
22 Sep 2026Press continues to report the pending KFTC sanction processDecision outstanding
2 Oct 2026Shares close at KRW 10,890 (+6.9% on the day)Market cap KRW 529.8 bn

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue fell from KRW 1,570.1 Bn in FY2021 to KRW 1,452.3 Bn in FY2025.
Aekyung Chemical Co., Ltd. — Income Statement: Revenue & Gross Profit
Series (KRW Bn)FY2021FY2022FY2023FY2024FY2025
Revenue1,570.12,176.41,793.71,642.21,452.3
Cost of sales1,412.21,954.31,617.71,501.41,333.3
Gross profit157.9222.1176.1140.8119

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.